Stocktwits on MSN

SLS stock tanks hard: Retail traders blame warrant holders, 'flippers' cashing out before AML catalyst

Retail investors said heavy warrant activity may have injected another $20 million-$30 million into Sellas’ cash position, while helping clear the stock’s warrant overhang. ・Some traders also blamed ...
Stocktwits on MSN

SLS stock surges into conference season as investors hunt for AML readout hints

Investors are watching three upcoming Sellas healthcare and cancer conferences this month. ・Sellas’ Phase 3 Regal AML study is now just two events away from final analysis and topline data. ・Sellas ...
The Globe and Mail

SELLAS Raises $26.5 Million Through Warrant Exercises

SELLAS Life Sciences Group ( (SLS)) just unveiled an update. Subsequent to December 31, 2025, SELLAS Life Sciences Group, a biopharmaceutical company, received approximately $26.5 million in cash ...
The Globe and Mail

SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...